Programa de Pós-Graduação em Farmácia, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil.
School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom.
Mol Pharm. 2022 Aug 1;19(8):2765-2775. doi: 10.1021/acs.molpharmaceut.2c00122. Epub 2022 Jul 14.
A graphical analysis of both drug and coformer concentrations contributed by dissolving cocrystals is presented in the context of a simplified cocrystal phase diagram. The conceptual basis and analysis identify parameters that control cocrystal dissolution-drug supersaturation-precipitation (DSP) behavior. The important effects of coformer concentration, cocrystal dose, and cocrystal solubility on drug supersaturation levels are demonstrated and quantified by the DSP. While the studies presented rely on high and nonstoichiometric coformer concentrations contributed by the dissolving cocrystals, the concepts and findings can answer the question of whether and how much coformer should be added to cocrystal dissolution media or formulations.
本文提出了一种简化共晶相图中药物和共晶浓度的图形分析方法。该分析的理论基础和方法确定了控制共晶溶解-药物过饱和-沉淀(DSP)行为的参数。通过 DSP,研究证明并量化了共晶浓度、共晶剂量和共晶溶解度对药物过饱和度水平的重要影响。虽然所呈现的研究依赖于溶解共晶提供的高非化学计量共晶浓度,但这些概念和发现可以回答是否以及应向共晶溶解介质或制剂中添加多少共晶的问题。